We are transforming cancer diagnostics by providing innovative, scalable, and low-cost solutions.
Problem
Cancer diagnostics are often too expensive, or they require equipment and specialization that is inaccessible outside major metropolitan cancer centers.
Solution
A low cost gene expression assay that can be used in most laboratory settings to provide an accurate diagnosis without expert review.
Publications
”Low-Cost, Transcriptional Diagnostic to Accurately Categorize Lymphomas in Low- and Middle-Income Countries” Full Manuscript: Blood Advances 2021 May 25;5(10):2447-2455. PMID: 33988700